Number of Shares
212,601.00
Current Holdings Value*
$13.57 Mil
% of Portfolio
0.33%
Total Estimate Gain
$9.48 Mil
% of Total Estimate Gain
138.35%

Master Small Cap Index Series's Halozyme Therapeutics Inc Holding Summary

As of 2025-03-31, QUANTITATIVE MASTER SERIES LLC held 212,601.00 shares of Halozyme Therapeutics Inc(HALO), totaling $13.57 Mil. This investment constitutes 0.33% of their stock portfolio, and QUANTITATIVE MASTER SERIES LLC now holds 0.17% of the outstanding Halozyme Therapeutics Inc(HALO) stock.

The initial trade took place in 2019Q3. And since then Master Small Cap Index Series has made 11 purchases of HALO, at an average price of $22.09, for a total of 310,240.00 shares. In addition, there have been 10 sales at an average price of $41.45 for 97,639.00 shares. Based on historical transaction data and HALO's current price of $57.81, Master Small Cap Index Series's estimated gain on his HALO holdings is $9.48 Mil, reflecting a 138.35% gain to date.

Master Small Cap Index Series HALO ($57.81) Holding Chart

Master Small Cap Index Series HALO ($57.81) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1